SavedAdd your journal

Journals / Sağlık Bilimleri Dergisi / 2014 / Cilt: 23 - Sayı: 1

DRUG INTERACTIONS BETWEEN DRUGS USED IN CARDIOVASCULAR SYSTEM DISEASES AND DRUGS USED IN ENDODONTIC TREATMENT SYSTEMATICALLY

KARDİYOVASKÜLER SİSTEM HASTALIKLARINDA KULLANILAN İLAÇLAR İLE ENDODONTİDE SİSTEMİK OLARAK KULLANILAN İLAÇLAR ARASINDAKİ İLAÇ ETKİLEŞİMLERİ

Gökhan SAYGILI
Hüseyin ERTAŞ
Hakan ARSLAN
Yusuf Cem KAPLAN
Elif TARIM ERTAŞ
İsmail Davut ÇAPAR
Pages
38–46
Publication Date
2014-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to provide information on drug interactions between drugs used in cardiovascular system diseases and drugs used in endodontic treatment systematically

📌 3 Key Takeaways

🎯
Objective & Hypothesis:During endodontic treatment various drugs could be prescribed to the patients with cardiovascular diseases.
📊
Key Findings & Data:These prescribed drugs could be used together with the drugs which has already used by the patient.
💡
Conclusion & Impact:The aim of this review is to provide information on drug interactions between drugs used in cardiovascular system diseases and drugs used in endodontic treatment systematically
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Analjezik · antibiyotik · endodonti

Abstract

During endodontic treatment various drugs could be prescribed to the patients with cardiovascular diseases. These prescribed drugs could be used together with the drugs which has already used by the patient. Combined use of two drugs can cause drug interactions as well as other drug reactions. The aim of this review is to provide information on drug interactions between drugs used in cardiovascular system diseases and drugs used in endodontic treatment systematically

Özet

-

🔖

Cite This Article

SAYGILI, G., ERTAŞ, H., ARSLAN, H., KAPLAN, Y. C., ERTAŞ, E. T., ÇAPAR, İ. D. (2014). DRUG INTERACTIONS BETWEEN DRUGS USED IN CARDIOVASCULAR SYSTEM DISEASES AND DRUGS USED IN ENDODONTIC TREATMENT SYSTEMATICALLY. Sağlık Bilimleri Dergisi, Cilt: 23 - Sayı: 1, 38–46. https://ajindex.com/articles/155135

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255- 1259
  2. Onat A, Ugur M, Cicek G, ve ark. Kırsal kesim ve kentlerde benzer kardiyovaskü ler ölü m riski. Tü rk Kardiyol Dern Arş 2010; 38: 159-163
  3. Arslan S, Atalay A, Kutsal Y. Yaşlılarda ilaç kullanımı. Geriatri 2000; 3: 56-60
  4. Ingle JI, Glick DH. Different diagnosıs and treatment of dental pain. In: Ingle JI, Taintor FC (eds). Endodontics. (3rd ed), Philadelphia, Lea & Febiger 1985; pp 288-289
  5. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-306
  6. Levy M, Kewitz H, Altwein W, et al. Hospital admissions due to adverse drug reactions: A comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 1980; 17: 25-31
  7. Schneeweiss S, Hasford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285-291. 8. van der Hooft CS, Sturkenboom MC, van Grootheest K, et al. Adverse drug reaction- related hospitalisations: A nationwide study in The Netherlands. Drug Saf 2006; 29: 161-168
  8. Fuhr U. Improvement in the handling of drug-drug interactions. Eur J Clin Pharmacol 2008; 64: 167-171
  9. Delpó n E GCF. Fá rmacos antiarrı́tmicos. En: Tamargo J. (coord). Farmacologı́a cardiovascular. Acció n Médica 2009; pp. 15- 38
  10. Singh BN, Vaughan Williams EM. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 1970; 39: 675-687
  11. Cazzola M, Blasi F, Ewig S. Antibiotics and the Lung. European Respiratory Society Monograph (Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections) 2004; 28: 229-254
  12. Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents 2001; 18: S71-S76 17. Paar D, Terjung B, Sauerbruch T. Life- threatening interaction between clarithromycin and disopyramide. Lancet 1997; 349: 326-327
  13. Henneman A, Thornby KA. Risk of hypotension with concomitant use of calcium- channel blockers and macrolide antibiotics. Am J Health Syst Pharm 2012; 69: 1038-1043
  14. Wright AJ, Gomes T, Mamdani MM, et al. The risk of hypot